Dr. Alireza Sedarat, MD

Dr. Sedarat practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Sedarat's NPI, 1629133913, was assigned on December 27, 2006. Dr. Sedarat graduated from Rutgers New Jersey Medical School in 2005. Dr. Sedarat holds California license A108616.

Dr. Sedarat's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Sedarat's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Sedarat is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Sedarat to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sedarat practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sedarat's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Sedarat is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Sedarat's licenses on file in 3 states: California, New Jersey and Pennsylvania.

Dmand AI lists acid reflux, chronic indigestion, colonoscopy, gastroduodenitis, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Sedarat treats.

CMS data shows 1,161 Medicare services from Dr. Sedarat across 25 procedure codes in 2024, for 496 Medicare patients. Medicare paid $133,361 for them.

CMS counts 496 Medicare patients who saw Dr. Sedarat in 2024. The largest group is 65 to 74, with 232 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sedarat's median patient age at 64, with 52% women.

In 2024, Dr. Sedarat wrote 161 Medicare Part D claims for 84 patients. 93% of them were for generic drugs. CMS names the drug for 120 of them, across 4 drugs with 11 or more claims each, at $3,797 in total drug cost. In 2023, CMS named 70 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sedarat for performance year 2024, reported as part of a group. Dr. Sedarat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sedarat as offering telehealth. CMS counts 561 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Sedarat, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 22 papers to Dr. Sedarat, published from 2006 to 2021. 2021 was the busiest year, with 4. The most frequent topics are Endoscopy, Gastrointestinal, Endosonography and Esophageal Achalasia. Dr. Sedarat has published most often in Gastrointest Endosc. Dr. Sedarat's most frequent co-authors are Rabindra Richard Watson, MD, Olaya Isabella Brewer Gutierrez, MD and Mouen A. Khashab, MD.

CMS Open Payments shows 378 general payments to Dr. Sedarat from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Boston Scientific Corporation paid the most, $100,274.

Dmand AI lists 1 award for Dr. Sedarat, most recently CMS Stage 1 EHR in 2012.

Dr. Sedarat graduated from Rutgers New Jersey Medical School in 2005.

Dr. Sedarat is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.